Metabolic & Body Comp
Preclinical
Research chemical

HGH Fragment 176-191

Also known as Frag 176-191 · hGH Frag

New

Reconstitution & dosing guide

1 mg · 2 mg · 5 mg · 10 mg vial sizes — research phases, recon steps, and a live unit calculator.

Open guide

Available sizes & price

Catalog only

10mg x 10 vials

Frag 17-23 · Not in current stock

$25 / vial

Add

1mg x 10 vials

HGH Fragment 176-191 (FR1) · Not in current stock

$20 / vial

Add

10mg x 10 vials

HGH Fragment 176-191 (FR10) · Not in current stock

$40 / vial

Add

2mg x 10 vials

HGH Fragment 176-191 (FR2) · Not in current stock

$20 / vial

Add

5mg x 10 vials

HGH Fragment 176-191 (FR5) · Not in current stock

$25 / vial

Add

Prices per vial · Research use only · Not medical advice.

C-terminal hGH fragment marketed for lipolysis; closely related to AOD-9604 discussions.

How to picture it

This C-terminal piece of GH is studied as the "fat-mobilizing page" of the larger hormone — lipolysis-oriented signaling without the full growth-promoting program of intact GH. Picture cutting one chapter out of the GH manual for metabolic targeting: body-composition research aimed at fat pathways rather than systemic anabolism.

Research focus & benefits

  • Fat-mobilization pathway research
  • GH-fragment metabolic studies
  • Body-composition science without full GH effects

Benefits describe research interest and pathway rationale — not guaranteed outcomes or medical advice. Research use only.

Overview

Fragment 176-191 is a piece of the HGH molecule associated with fat-metabolism research. It is often compared with AOD-9604. Human evidence quality is limited relative to modern incretin drugs.

Mechanism

Proposed selective lipolytic signaling without full GH anabolic cascade.

Research uses

  • Adipose metabolism research

Research dosing notes

Often discussed as fasted morning / pre-cardio injections in forums — not clinical guidance.

Open full reconstitution & dosing guide →

Half-life / kinetics

Short

Common research routes

Subcutaneous injection

Reported considerations

  • Injection irritation
  • Unknown durability of effect

Contraindications / cautions

  • Pregnancy
  • Serious metabolic disease without medical care

Common research stacks

  • AOD-9604 comparisons
  • CJC/IPA
  • L-carnitine (anecdotal stacks)

Legal / access note

Research chemical; not an approved weight-loss drug.